FOLH1 and posterior cortical atrophy: Consequently, our data encourage the usage of 68Ga-PSMA-PET and mpMRI for biopsy guidance and planning of focal therapies and show that 68Ga-PSMA-PET should at least be performed in patients with intermediate and high-risk PCa since it gives highly complementary information.